ArticlePediatric research2026
Exit site management: neonatal european vascular access team - ESPR recommendation 7.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNeonatal skin immaturity, increased transepidermal water loss, prolonged catheter dwell times, and repeated dressing manipulation expose neonates to a high risk of catheter-related infection, skin injury, dressing failure, and device dislodgement. Standardized exit site management is therefore a fundamental component of neonatal vascular access care. This article is part of a special series of ten recommendations for the management of neonatal vascular access, developed through a structured multidisciplinary consensus process integrating literature appraisal and expert deliberation. METHODS AND CLINICAL APPLICATION: This recommendation provides evidence-based guidance for the management of exit sites of peripheral venous access devices, central venous access devices, and intra-arterial catheters in neonates. Key components include standardized assessment of the exit site and skin condition, risk-based application of Standard-ANTT® or Surgical-ANTT®, skin antisepsis adapted to gestational age, use of chlorhexidine-based solutions, securement with sutureless devices, application of octyl-butyl-cyanoacrylate glue, and use of semipermeable transparent dressings with high moisture vapor transmission rate (MVTR). Recommendations for dressing changes, complication monitoring, and catheter removal are also provided.
conclusionStandardized exit site management may reduce catheter-related infections, medical adhesive-related skin injury, dressing failure, and device dislodgement, while improving consistency of care and patient safety across neonatal units. IMPACT: This recommendation provides evidence-based strategies for neonatal vascular access exit site management, including dressing selection, antisepsis, securement, and skin protection. Standardized exit site care may reduce catheter-related infections, dressing failure, skin injury, and device dislodgement in neonates. The recommendation promotes consistent use of aseptic non-touch technique (ANTT®), securement systems, and high MVTR dressings to preserve skin integrity and improve catheter stability. Implementing standardized exit site management practices enhances patient safety and reduces practice variation across neonatal centers.
Identifiers
42763318What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.